{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:15:52Z","timestamp":1774620952603,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejpn.2014.11.008","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:12Z","timestamp":1417305612000},"page":"248-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Extending the use of stiripentol to other epileptic syndromes: A case of PCDH19-related epilepsy"],"prefix":"10.1016","volume":"19","author":[{"given":"Marina","family":"Trivisano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Specchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Vigevano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2014.11.008_bib1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.06.004","article-title":"The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator","volume":"56","author":"Fisher","year":"2009","journal-title":"Neuropharm"},{"key":"10.1016\/j.ejpn.2014.11.008_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nurt.2006.10.001","article-title":"Stiripentol","volume":"4","author":"Chiron","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejpn.2014.11.008_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/dmd.105.007237","article-title":"In\u00a0vitro and in\u00a0vivo inhibitory effect of stiripentol on clobazam metabolism","volume":"34","author":"Giraud","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ejpn.2014.11.008_bib4","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1528-1157.1999.tb02048.x","article-title":"Stiripentol: efficacy and tolerability in children with epilepsy","volume":"40","author":"Perez","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.008_bib5","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2014.11.008_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/epi.12303","article-title":"Stiripentol in Dravet syndrome: results of a retrospective U.S. study","volume":"54","author":"Wirrell","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.008_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/08830738060210062101","article-title":"Stiripentol in childhood partial epilepsy: a randomized placebo-controlled trial with enrichment and withdrawal design","volume":"21","author":"Chiron","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2014.11.008_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.braindev.2012.03.016","article-title":"Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam","volume":"35","author":"Merdariu","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.ejpn.2014.11.008_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1212\/WNL.0b013e3181ed9e67","article-title":"Protocadherin 19 mutations in girls with infantile onset epilepsy","volume":"75","author":"Marini","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2014.11.008_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1528-1167.2011.03063.x","article-title":"Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations","volume":"52","author":"Specchio","year":"2011","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ejpn.2014.11.008_bib11","doi-asserted-by":"crossref","first-page":"e1000381","DOI":"10.1371\/journal.pgen.1000381","article-title":"Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females","volume":"5","author":"Depienne","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ejpn.2014.11.008_bib12","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1528-1167.2012.03649.x","article-title":"Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy","volume":"53","author":"Marini","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.008_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1528-1157.1993.tb02416.x","article-title":"Stiripentol in atypical absence seizures in children: an open trial","volume":"34","author":"Farwell","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.11.008_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1528-1157.1995.tb00961.x","article-title":"Migrating partial seizures in infancy: a malignant disorder with developmental arrest","volume":"36","author":"Coppola","year":"1995","journal-title":"Epilepsia"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T19:38:31Z","timestamp":1566070711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1090379814001834"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.11.008","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extending the use of stiripentol to other epileptic syndromes: A case of PCDH19-related epilepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}